Chapter 53 provides benchmarks for pharmaceutical organizations. The 23 respondents in this subsector engages in the discovery, development, production, and distribution of prescription drugs, over-the-counter medicines, vaccines, biologics, and other therapeutic products. This subsector includes both research-based pharmaceutical companies and manufacturers focused on generic drugs and specialty treatments. The organizations in this sample range from about $70 million to about $65 billion in annual revenue.
Avasant’s research and other publications are based on information from the best available sources and Avasant’s independent assessment and analysis at the time of publication. Avasant takes no responsibility and assumes no liability for any error/omission or the accuracy of information contained in its research publications. Avasant does not endorse any provider, product or service described in its RadarView™ publications or any other research publications that it makes available to its users, and does not advise users to select only those providers recognized in these publications. Avasant disclaims all warranties, expressed or implied, including any warranties of merchantability or fitness for a particular purpose. None of the graphics, descriptions, research, excerpts, samples or any other content provided in the report(s) or any of its research publications may be reprinted, reproduced, redistributed or used for any external commercial purpose without prior permission from Avasant, LLC. All rights are reserved by Avasant, LLC.
Login to get free content each month and build your personal library at Avasant.com
This report is part of the Avasant Premium Research Subscription.
To gain access to this report, click the button below and an Account Executive will contact you within one business day.
Register or sign in to explore Avasant Research.
Open access is available to qualified buyer organizations. Register Now!
